These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 34952359)

  • 1. Genetic and transcriptomic analyses support a switch to lytic phase in Epstein Barr virus infection as an important driver in developing Systemic Lupus Erythematosus.
    Afrasiabi A; Keane JT; Ong LTC; Alinejad-Rokny H; Fewings NL; Booth DR; Parnell GP; Swaminathan S
    J Autoimmun; 2022 Feb; 127():102781. PubMed ID: 34952359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases.
    Niller HH; Wolf H; Minarovits J
    Autoimmunity; 2008 May; 41(4):298-328. PubMed ID: 18432410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene profiling of Epstein-Barr Virus and human endogenous retrovirus in peripheral blood mononuclear cells of SLE patients: immune response implications.
    Lemus YB; Martínez GA; Lugo LP; Escorcia LG; Peñata EZ; Llanos NS; Bonfanti AC; Acosta-Hoyos AJ; Quiroz EN
    Sci Rep; 2024 Aug; 14(1):20236. PubMed ID: 39215087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioinformatics analysis of the pathogenic link between Epstein-Barr virus infection, systemic lupus erythematosus and diffuse large B cell lymphoma.
    Zhu QY
    Sci Rep; 2023 Apr; 13(1):6310. PubMed ID: 37072474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The interaction of Epstein-Barr virus encoded transcription factor EBNA2 with multiple sclerosis risk loci is dependent on the risk genotype.
    Keane JT; Afrasiabi A; Schibeci SD; Swaminathan S; Parnell GP; Booth DR
    EBioMedicine; 2021 Sep; 71():103572. PubMed ID: 34488019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epstein‒Barr virus and human herpesvirus 6 infection in patients with systemic lupus erythematosus.
    Chen X; Li H; Wu C; Zhang Y
    Virol J; 2023 Feb; 20(1):29. PubMed ID: 36782252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence from genome wide association studies implicates reduced control of Epstein-Barr virus infection in multiple sclerosis susceptibility.
    Afrasiabi A; Parnell GP; Fewings N; Schibeci SD; Basuki MA; Chandramohan R; Zhou Y; Taylor B; Brown DA; Swaminathan S; McKay FC; Stewart GJ; Booth DR
    Genome Med; 2019 Apr; 11(1):26. PubMed ID: 31039804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aberrant Epstein-Barr viral infection in systemic lupus erythematosus.
    Poole BD; Templeton AK; Guthridge JM; Brown EJ; Harley JB; James JA
    Autoimmun Rev; 2009 Feb; 8(4):337-42. PubMed ID: 19167523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Shared and distinct interactions of type 1 and type 2 Epstein-Barr Nuclear Antigen 2 with the human genome.
    Viel KCMF; Parameswaran S; Donmez OA; Forney CR; Hass MR; Yin C; Jones SH; Prosser HK; Diouf AA; Gittens OE; Edsall LE; Chen X; Rowden H; Dunn KA; Guo R; VonHandorf A; Leong MML; Ernst K; Kaufman KM; Lawson LP; Gewurz B; Zhao B; Kottyan LC; Weirauch MT
    BMC Genomics; 2024 Mar; 25(1):273. PubMed ID: 38475709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiology of the Epstein-Barr Virus in Autoimmune Inflammatory Rheumatic Diseases in Northern Brazil.
    França SAS; Viana JBGO; Góes HCA; Fonseca RRS; Laurentino RV; Costa IB; Oliveira-Filho AB; Machado LFA
    Viruses; 2022 Mar; 14(4):. PubMed ID: 35458425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of clinical and serological parameters of systemic lupus erythematosus patients with Epstein-Barr virus antibody profile.
    Chougule D; Nadkar M; Rajadhyaksha A; Pandit-Shende P; Surve P; Dawkar N; Khadilkar P; Patwardhan M; Kaveri S; Ghosh K; Pradhan V
    J Med Virol; 2018 Mar; 90(3):559-563. PubMed ID: 28734074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The interaction of Multiple Sclerosis risk loci with Epstein-Barr virus phenotypes implicates the virus in pathogenesis.
    Afrasiabi A; Parnell GP; Swaminathan S; Stewart GJ; Booth DR
    Sci Rep; 2020 Jan; 10(1):193. PubMed ID: 31932685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gender and the Sex Hormone Estradiol Affect Multiple Sclerosis Risk Gene Expression in Epstein-Barr Virus-Infected B Cells.
    Keane JT; Afrasiabi A; Schibeci SD; Fewings N; Parnell GP; Swaminathan S; Booth DR
    Front Immunol; 2021; 12():732694. PubMed ID: 34566997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A retrospective cohort study of Epstein-Barr virus infection status and systemic lupus erythematosus.
    Chen M; Tu J; Huang M; Cheng Y; Sun L
    Clin Rheumatol; 2024 May; 43(5):1521-1530. PubMed ID: 38509241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epstein-Barr virus infection as potential indicator of the occurrence and clinical presentation of systemic lupus erythematosus.
    Banko A; Cirkovic A; Miskovic R; Jeremic I; Grk M; Basaric M; Lazarevic I; Raskovic S; Despotovic A; Miljanovic D
    Front Immunol; 2023; 14():1307589. PubMed ID: 38146370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Landscape of immune cells in systematic lupus erythematosus patients with Epstein-Barr virus infection: assessed by single-cell sequencing.
    Hu L; Tu J; Gui J; Fang M; Sun L
    Rheumatology (Oxford); 2024 Oct; 63(10):2856-2864. PubMed ID: 38078808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired Cytokine Responses to Epstein-Barr Virus Antigens in Systemic Lupus Erythematosus Patients.
    Draborg AH; Sandhu N; Larsen N; Lisander Larsen J; Jacobsen S; Houen G
    J Immunol Res; 2016; 2016():6473204. PubMed ID: 27110576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Investigation of Epstein-Barr virus and herpes simplex virus markers by serological and molecular methods in patients with rheumatoid arthritis and systemic lupus erythematosus].
    Us T; Cetin E; Kaşifoğlu N; Kaşifoğlu T; Akgün Y
    Mikrobiyol Bul; 2011 Oct; 45(4):677-83. PubMed ID: 22090298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epstein-Barr Virus Reactivation as a New Predictor of Achieving Remission or Lupus Low Disease Activity State in Patients with Systemic Lupus Erythematosus with Cutaneous Involvement.
    Miskovic R; Cirkovic A; Miljanovic D; Jeremic I; Grk M; Basaric M; Lazarevic I; Stojanovic M; Plavsic A; Raskovic S; Banko A
    Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epstein-Barr virus nuclear antigen EBNA-LP is essential for transforming naïve B cells, and facilitates recruitment of transcription factors to the viral genome.
    Szymula A; Palermo RD; Bayoumy A; Groves IJ; Ba Abdullah M; Holder B; White RE
    PLoS Pathog; 2018 Feb; 14(2):e1006890. PubMed ID: 29462212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.